Association Between FSIP2 Mutation and an Improved Efficacy of Immune Checkpoint Inhibitors in Patients With Skin Cutaneous Melanoma

Association Between FSIP2 Mutation and an Improved Efficacy of Immune Checkpoint Inhibitors in Patients With Skin Cutaneous Melanoma

BackgroundImmune checkpoint inhibitors (ICIs) have shown remarkable success in treating skin cutaneous melanoma (SKCM); however, the response to treatment varies greatly between patients. Considering that the efficacy of ICI treatment is influenced by many factors, we selected the Fibrosheath intera...

Full description

Bibliographic Details
Main Authors: Haoxuan Ying, Anqi Lin, Junyi Liang, Jian Zhang, Peng Luo
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-05-01
Series:Frontiers in Molecular Biosciences
Subjects:
skin cutaneous melanoma
Fibrosheath interacting protein 2
immune checkpoint inhibitor
tumor mutation burden
regulatory T cell
Online Access:https://www.frontiersin.org/articles/10.3389/fmolb.2021.629330/full

Internet

https://www.frontiersin.org/articles/10.3389/fmolb.2021.629330/full

Similar Items